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Introduction
The mammary gland is the specialized secretory organ that provides essential nourishment to mam-
malian young in the form of milk. Milk is primarily composed of water, fats, lactose and proteins;
the major protein components are the various caseins and the whey proteins \g=a\-lactalbumin,
\g=b\-lactoglobulin(ruminants) and whey acidic protein (rodents).
Mammary development and milk protein gene expression are regulated by a number of peptide
and steroid hormones, as well as cell-cell and cell-substratum interactions within the gland
(Topper & Freeman, 1980; Levine & Stockdale, 1985; Li et ai, 1987). During gestation the se¬
cretory capacity of the mammary gland increases due to cellular proliferation and differentiation;
concomitantly milk protein gene expression is initiated in preparation for sustained milk produc¬
tion after parturition. In late lactation milk production declines due to decreased demand, and at
weaning rapid mammary gland involution occurs to a state that approximates that of the mature
virgin gland. Our present understanding of the relative contribution that hormones and morpho¬
logical factors have on mammary gland development and milk protein gene expression results from
investigations in the whole animal and in vitro, including mammary gland expiants (Topper et ai,
1975) and mammary epithelial cell culture systems (Rosen et ai, 1986).
Man has traditionally exploited ruminant milk and its products as a source of dietary protein
and in the food technology industry (see Fox, 1982). It has recently been proposed that manipu¬
lation of milk composition is a candidate for genetic manipulation in domestic dairy animals
(Wagner & Murray, 1985; Lathe et ai, 1986; Clark et ai, 1987; Jiménez-Flores & Richardson,
1988). Several groups have successfully demonstrated the feasibility of targeting gene expression to
the mammary gland of mice (Stewart et ai, 1984; Ross & Solter, 1985; Leder et ai, 1986; Andres et
ai, 1987; Choi et ai, 1987; Gordon et ai, 1987; Simons et ai, 1987; Lee et ai, 1988; Muller et ai,
1988; Schonenberger et ai, 1988; Tsukamoto et ai, 1988; Bouchard et ai, 1989; Lee et ai, 1989;
Tremblay et ai, 1989). In Edinburgh, transgenic sheep carrying hybrid gene constructs that express
a human plasma protein in their milk have been generated (Simons et ai, 1988; Clark et ai, 1989).
At present the levels of expression of the transgenic protein in the milk are low and this illustrates
the need for a greater understanding of the structure and regulation of the milk protein genes used
to target expression to the mammary gland (Clark et ai, 1989).
A number of genomic clones encoding milk proteins have been isolated and their organizations
described (Yu-Lee & Rosen, 1983; Campbell et ai, 1984; Qasba & Safaya, 1984; Jones et ai, 1985;
David-Inouye et ai, 1986; Yu-Lee et ai, 1986; Hall et ai, 1987; Kawara et ai, 1987; Vilotte et ai,
1987; Alexander et ai, 1988; Ali & Clark, 1988; Devinoy et ai, 1988; Gorodetsky et ai, 1988; Laird
et ai, 1988). The identification of DNA sequence elements that contribute to regulated milk protein
*Present address: Glaxo Group Research Ltd, Greenford Road, Greenford, Middlesex UB6 OHE, UK.
tPresent address: INSERM U184 CNRS LGME, Institute de Chimie Biologique, Faculté de Médecine, 11 Rue
Humann, 67085 Strasbourg Cedex, France.
gene expression has been impeded by the absence of a suitable system in which to evaluate expres¬
sion of manipulation DNA sequences. Intra- and inter-species DNA sequence comparisons have
suggested common regulatory elements in the promoter region of a number of different caseins and
whey proteins (Yu-Lee & Rosen, 1983; Jones et ai, 1985; Yu-Lee et ai, 1986; Bisbee & Rosen,
1986; Hall et ai, 1987; Devinoy et ai, 1988; Laird et ai, 1988). Furthermore, an in-vitro
DNA-protein interaction has been proposed between part of this DNA sequence motif and nuclear
protein(s) isolated from various tissues, including the mammary gland (Lubon & Hennighausen,
1987, 1988). A cell system has been described that allows characterization of the rat ß-casein pro¬
moter covering this region (Ball et ai, 1988; Doppler et ai, 1989); the applicability of this cell
system to other milk protein genes has yet to be demonstrated. While the significance in vivo of
these observations remains unclear, the advent of methods for generating transgenic animals
containing manipulated DNA sequences allows the investigation of milk protein gene expression in
the whole animal, under the influence of all contributory factors.
Generation of transgenic animals
There are currently three methods for incorporating exogenous DNA into the genome to produce
transgenic animals. These are (1) retroviral vectors, (2) embryonic stem cells and (3) pronuclear
microinjection (Palmiter & Brinster, 1986; Scangos & Bieberich, 1987; Simons & Land, 1987). At
present most transgenic animals are produced by pronuclear microinjection of fertilized eggs(Fig. 1). Fertilized eggs are obtained from superovulated donor animals and tens to hundreds of
DNA molecules are injected through a fine injection pipette into one of the pronuclei. Surviving
eggs are implanted into foster mothers and proceed to term.
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Fig. 1. Production of transgenic mice by pronuclear injection (see text for details).
Transgenic offspring are identified by molecular analysis of their DNA for the presence of the
injected DNA molecule(s). The integrated DNA is frequently present in every cell at a single
chromosomal location, usually as multiple copies in a tandem array. In mice up to 5% of injected
eggs may develop to be transgenic. In domestic animals, such as sheep or pigs, the average success
rate is approximately 1%. This may reflect differences in both reproductive physiology and the
technical demands of microinjection into more fragile and almost opaque eggs (Simons et ai,
1988).
Ovine ß-lactoglobulin
We have chosen to investigate expression of the gene encoding ovine ß-lactoglobulin (BLG).
ß-Lactoglobulin is a whey protein of
  
18 000 present in ruminant milk at a concentration of
about 3 g/1. It is also found in the milk of horses, pigs, dogs and dolphins, but not in that of rodents
and humans (Jenness, 1982; Pervaiz & Brew, 1985). While the protein has no recognized function it
is related to a diverse family of other secretory proteins, many of which bind small lipophilic
molecules (for references, see Ali & Clark, 1988; Ali, 1989). The genomic ovine BLG gene has been
isolated and more than 7 kb of the DNA sequence encompassing the structural gene have been
determined (Ali & Clark, 1988; Harris et ai, 1988). The DNA sequence suggests that a functional
gene has been isolated, not a pseudogene, and that the pre-protein of 180 amino acids is encoded by
7 exons covering 4-9 kb of genomic DNA (Fig. 2). However, it remained to be demonstrated
whether the isolated BLG gene contains the necessary eis regulatory sequences for efficient,
regulated expression in the mammary gland.
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Fig. 2. Organization of the ovine ß-lactoglobulin clone SSI. (a) Bold line represents 5' and 3'
flanking DNA while exon and intron sequences (not to scale) are represented by stippled and
open boxes, respectively, (b) The extent of various regions of DNA used to generate transgenic
mice by pronuclear injection: 7 and 45 correspond to lines of mice generated with the particular
region illustrated (for results see Figs 3, 4 and 5) while   ,   1,   2 and   are construct
identifiers.
In the absence of a suitable in-vitro cell system in which to evaluate BLG expression we have
investigated the ability of various BLG DNA constructs to direct the expression of BLG protein in
milk of transgenic mice (Simons et ai, 1987; S. Harris, P. Simons & M. McClenaghan, unpublished
results). In parallel, we are also investigating the potential of transgenic sheep containing BLG-
fusion genes as a source of authentic human protein in milk (Simons et ai, 1988; Clark et ai,
1989; A. Archibald, unpublished results). A mouse system would therefore be a rapid means of
evaluating BLG-fusion constructs for their potential to direct the expression of a foreign protein in
the milk of a domestic ruminant.
The mouse model system
To evaluate sheep BLG expression in mice, genomic DNA sequences must be correctly transcribed,
mRNA translated, and the protein correctly processed and secreted into the milk, despite the
absence of the BLG gene in mice. The ability of transgenes to direct the production of BLG protein
or BLG-fusion gene products in a tissue-specific, regulated manner requires the presence of ex¬
acting DNA sequences that control BLG expression. In the absence of any information regarding
the position of such sequences within the ovine clone SSI, the largest genomic DNA fragment from
this clone was initially used to produce transgenic mice (Simons et ai, 1987). Additional lines of
mice have been generated containing derivative BLG constructs to define more precisely those cis-
acting DNA sequence elements important for tissue-specific, regulated expression (Simons et ai,
1987; Fig. 2).
The ability of various BLG constructs to direct the expression of BLG in mouse milk can
generally be assessed by SDS polyacrylamide gel electrophoresis and Coomassie Blue staining of
milk whey proteins as shown in Fig. 3(a). An additional protein of Mr 18 000 is present in milk from
lactating transgenic mice, all other protein bands being present in milk from transgenic and control
animals. This additional protein co-migrates with purified BLG, and western blotting of milk whey
proteins confirms the identity of this protein as BLG (Fig. 3b). In abundantly expressing lines the
level of BLG protein in mouse milk can be up to 5 times that present in sheep milk (e.g. line 7). This
change in milk composition is not accompanied by any apparent deleterious side effects, either to
the hemizygous transgenic females or their sucking offspring. Copy number-independent variations
in BLG protein content are evident in different lines of mice containing the same BLG construct
(e.g. lines 23 & 41), probably reflecting the influence of the site of integration on transgene
expression in different lines (Palmiter & Brinster, 1986).
All the 5' and 3' flanking deletion constructs express similarly variable levels of BLG protein in
the milk of transgenic mice (Fig. 2; S. Harris & M. McClenaghan, unpublished results). In contrast,
the milk from three GO females containing the intronless BLG construct (  , Fig. 2) express a
consistently low level of protein, detectable only by western blotting (S. Harris & M. McClenaghan
unpublished results). This suggests a possible requirement for intron sequences for efficient BLG
expression in transgenic mice. However, the ability of the BLG promoter region to direct signifi¬
cant levels of a foreign protein from a genomic DNA sequence containing introns (A. Archibald,
unpublished results) suggests this may be a non-specific requirement, rather than a requirement for
specific BLG intron sequences. It is also possible, although unlikely, that all 3 animals were either
somatic mosaics or low level expressors, due to the site of integration. The dependence of gene
expression on the presence of intron sequences has been noted by others (Brinster et ai, 1988).
Further lines of mice would need to be analysed to clarify the mechanism(s) by which, intron
sequences influence BLG expression in transgenic systems.
The tissue distribution of BLG expression has been examined in total RNA isolated from a
variety of tissues and analysed after Northern blotting using BLG-specific cDNA probes (Simons
et ai, 1987; Fig. 4). Mice expressing BLG protein in their milk contain a transcript present in RNA
isolated from the lactating mammary gland that co-migrates with the equivalent sheep transcript of
about 800 nucleotides (Gaye et ai, 1986). All BLG deletion constructs retain this strict tissue-
specific expression pattern in transgenic mice, including the intronless gene (S. Harris, unpublished
results). Furthermore, in all lines examined the RNA transcript initiates at the previously identified
Fig. 3. Analysis of whey proteins in the milk of mice transgenic for sheep ß-lactogobulin (BLG)(a) Milk samples were diluted 1/5 in distilled water and defatted by centrifugation. To prepare
whey, the caseins were precipitated by the addition of 1 m-HCI to pH 4-5. Whey proteins(150 µ ) were precipitated in 5% TCA, washed in acetone, solubilized in
   µ loading buffer
and electrophoresed on 15% polyacrylamide gels. Solubilized whey protein (2-0 µ ) from each
transgenic mouse (as numbered) and one control mouse (CM) are shown electrophoresed
alongside 100 µ sheep whey protein (S), markers (M) and 2-5 µg (a) and 10 µg (b) of purified
sheep BLG. (b) Western blot of whey proteins probed for sheep BLG. Samples from transgenic
animals are in numbered lanes, from control mouse in lane CM and from sheep in lane S.
Solubilized whey (1 µ is equivalent to 0-3 µ milk) was loaded as follows: 0T µ for all trans¬
genic samples except 7 (0-5 µ ); 23-5 and 23-9 (3 µ ); 8, 23 and 37 (5 µ ); 1 µ for CM and S, 3 µ .Standards are shown in lanes a, b, c and d and correspond to 100, 500, 2 and 100 ng purified
BLG, respectively: note that a and b apply to the first 10 lanes, c to lanes 8, 23 and 37 and d to
lanes 23-5 and 23-9. The high Mr band in tracks 8, 23 and 37 is due to non-specific binding of
the antiserum. For further details see Simons et ai (1987). Part of figure reproduced by per¬
mission from Simons et ai (1987).
cap site (Ali, 1989; P. Brown & S. Harris, unpublished results). Moreover, when examined by
immunohistochemical analysis, BLG protein expression is specific to the secretory epithelial cells
within the mammary gland (S. Harris & M. McClenaghan, unpublished results).
Fig. 4. Tissue-specific expression of the sheep BLG gene in the mammary gland of transgenic
mice. Northern blot analysis of 5 µg total RNA from 11-day lactating transgenic mice(numbered) and a control animal C57BL/6 (CM). The tissues analysed are mammary gland(Ma), liver (Li), kidney (Ki), spleen (Sp), salivary gland (Sa), and lachrymal gland (La). Lane
S = RNA from the mammary gland of a lactating ewe. Duplicate transgenic mice give essen¬
tially identical results. For further experimental details see Simons et ai (1987). Reprinted by
permission from Simons et ai (1987).
Occasionally a low abundance RNA transcript could be seen in other tissues after a long
exposure, particularly in the salivary gland. This is most likely to be due to contamination of this
tissue during dissection by thoracic mammary gland tissue because (1) other endogenous murine
mammary specific transcripts that are known not to be expressed in the salivary gland are also
present (e.g. ß-casein), and (2) the quantity of salivary gland BLG transcript present in a given
RNA sample fluctuates for a given transgenic line.
We have demonstrated abundant tissue-specific expression of the ovine BLG gene in transgenic
mice. However, for the mouse model to be a useful representation of BLG gene expression in sheep
it is also important that gene expression is temporally and developmentally regulated rather than
constitutive. To examine this aspect of regulation in transgenic mice total RNA was isolated from
virgin mice and other animals killed at specific times during gestation, lactation and weaning. Using
RNA dot-blot analysis the level of BLG-specific RNA was determined for each time point (Fig. 5;
S. Harris, unpublished).
Fig. 5. Expression of the ovine ß-lactoglobulin gene during gestation in transgenic mice. Total
RNA values isolated from mammary gland tissue at different days during gestation are shown
after hybridization to 32P-labelled DNA probes. RNA samples were transferred to filters
through a manifold. Control mouse (C57BL/6), control sheep and 11-day post-parturient
RNA samples were diluted 10-fold compared to gestation samples (line 7, see Fig. 1). The ovine
ß-lactoglobulin probe was derived from p931 (Gaye et ai, 1986); the murine ß-casein probe was
from pCas51 (Mehta et ai, 1981); the murine WAP probe from pmWAPl (Hennighausen &
Sippel, 1982) and the Xenopus ribosomal rDNA probe was from pMB9 (Sollner-Webb &
Reeder, 1979).
When the expression profile for BLG is compared to that of RNA encoding other endogenous
murine milk proteins, BLG is expressed with a developmental profile similar to that of endogenous
murine ß-casein, but different from that of the murine whey acidic protein. This BLG expression
profile in mice resembles that established for BLG in sheep when equivalent time points are
examined (Ali, 1989). Similar results are also obtained for deletion constructs over a limited time
course (S. Harris, unpublished results). These observations, that the BLG transgene is temporally
and developmentally regulated in transgenic mice, suggest that all the essential cw-acting DNA
sequences required for regulated expression of the ovine BLG gene are represented within the
deletion construct   2 (Fig. 1).
Summary and conclusions
We have demonstrated that the ovine genomic clone SSI can be used to generate transgenic mice
that produce significant quantities of BLG protein in milk. The smallest BLG construct so far
examined that retains the ability to direct BLG to mouse milk encompasses approximately 7-3 kb
of genomic DNA, of which about 0-8 kb is derived from the promoter region. Gene expression is
tissue-specific and regulated in a temporal and developmental fashion that is similar to that
reported for sheep. We conclude, therefore, that the cw-acting sequences determining mammary
expression of the ovine BLG gene are correctly interpreted in mice, despite the absence of an
equivalent gene in this species, and that conclusions drawn from future work on BLG expression in
the mammary gland of transgenic mice will be broadly applicable in sheep and other ruminant
species.
Work is currently in progress to define other sequences within the promoter of BLG that are
required for regulated expression in transgenic mice. These and other studies into the DNA-protein
interactions within the promoter which are required for efficient tissue-specific, regulated expres¬
sion should lead to a greater understanding of milk protein gene expression in the mammary gland.
Furthermore, in the current absence of a suitable in-vitro system, the mouse will be most useful for
evaluating the expression of further constructs designed to express foreign proteins in milk of
domestic ruminants.
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